Recombinant asporin and synthetic peptide fragments inhibit MDA-MB-468 cells by inhibiting TGF-β1-mediated SMAD2 phosphorylation and EMT, which significantly reduces tumor growth (Maris et al. 2015; Mizutani et al. 2019). Here, TGFB1 is linked to neoplasm.